| P50 | author | Akira Ishiguro | Q85227034 |
| P2093 | author name string | Jun-ichiro Inoue | |
| | Taishin Akiyama | |
| | Yoshikazu Nakamura | |
| | Hironori Adachi | |
| P2860 | cites work | Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction | Q24676400 |
| | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 |
| | IL-17 and Th17 Cells | Q27860566 |
| | Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase | Q27860794 |
| | In vitro selection of RNA molecules that bind specific ligands | Q27861109 |
| | Interleukin-17 and type 17 helper T cells | Q28256510 |
| | A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 |
| | Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor | Q28609151 |
| | Molecular antagonism and plasticity of regulatory and inflammatory T cell programs | Q29619478 |
| | Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 |
| | Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis | Q33908167 |
| | IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines | Q34090258 |
| | LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study | Q34096856 |
| | Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. | Q34474493 |
| | Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease | Q34499843 |
| | Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). | Q34506884 |
| | A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis | Q34575053 |
| | Neutrophilic airway inflammation and IL-17. | Q34778056 |
| | RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes | Q35057518 |
| | Unmet needs in rheumatoid arthritis | Q36165321 |
| | Interleukin-17 is a negative regulator of established allergic asthma | Q36228146 |
| | Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population | Q36499318 |
| | Regulation of inflammatory responses by IL-17F | Q36639980 |
| | Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G | Q36666265 |
| | Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity | Q36991727 |
| | Aptamers as candidate therapeutics for cardiovascular indications | Q37068323 |
| | Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis | Q37121507 |
| | Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. | Q37193763 |
| | Differentiation and function of pro-inflammatory Th17 cells | Q37231613 |
| | Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro | Q38318856 |
| | Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. | Q38594831 |
| | Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells | Q42170048 |
| | RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis | Q43171380 |
| | Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. | Q44398367 |
| | Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice | Q44807490 |
| | Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase | Q46724756 |
| P433 | issue | 2 | |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 455-466 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models | |
| P478 | volume | 63 | |